(Q83277288)

English

High-dose melphalan (200 mg/m2) supported by autologous stem cell transplantation is safe and effective in elderly (>or=65 years) myeloma patients: comparison with younger patients treated on the same protocol

scientific article published on 01 May 2006

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16670701%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

High-dose melphalan (200 mg/m2) supported by autologous stem cell transplantation is safe and effective in elderly (>or=65 years) myeloma patients: comparison with younger patients treated on the same protocol (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16670701%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Jantunen E

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16670701%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Kuittinen T

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16670701%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Penttilä K

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16670701%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Lehtonen P

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16670701%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Mahlamäki E

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16670701%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Nousiainen T

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16670701%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

1 May 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16670701%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16670701%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16670701%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16670701%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

917-922

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16670701%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705360

0 references

Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol. Cooperative Group of Study and Treatment of Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple myeloma in elderly patients: presenting features and outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of autologous transplantation in patients with multiple myeloma aged 65 years and over

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergrou

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose intravenous melphalan: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose or intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study on feasibility and efficacy of amifostine preceding high-dose melphalan with autologous stem cell support in myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral stem cell mobilization and engraftment in patients over age 60

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation between harvest success and outcome after autologous peripheral blood stem cell transplantation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

Palifermin for oral mucositis after intensive therapy for hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

An elective single autograft with high-dose melphalan: single-center study of 451 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705360

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83277288&oldid=1465433078"